Advanced search
Publication Cover
Cell Cycle Volume 11, 2012 - Issue 9
Submit an article Journal homepage
1,942
Views
56
CrossRef citations to date
0
Altmetric
Report

Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes

Olga A. Issaenko Russian Academy of Science; St. Petersburg, Russia; University of Minnesota; Minneapolis, MN USACorrespondence[email protected]
&
Alexander Yu Amerik Brown University; Providence, RI USA
Pages 1804-1817 | Received 31 Jan 2012, Accepted 27 Mar 2012, Published online: 01 May 2012

Citations (56)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Amira A. Alakhdar, Amr H. Saleh & Reem K. Arafa. (2022) Targeting homologous recombination (HR) repair mechanism for cancer treatment: discovery of new potential UCHL-3 inhibitors via virtual screening, molecular dynamics and binding mode analysis. Journal of Biomolecular Structure and Dynamics 40:1, pages 276-289.
Read now
Olga A. Issaenko & Alexander Yu Amerik. (2012) Erratum to Issaenko OA, et al. Cell Cycle Volume 11, Issue 9; pp. 1804-17. Cell Cycle 11:18, pages 3518-3518.
Read now

Articles from other publishers (54)

Si-Ting Gao, Xin Xin, Zhuo-yuan Wang, Yi-yang Hu & Qin Feng. (2024) USP5: Comprehensive insights into structure, function, biological and disease-related implications, and emerging therapeutic opportunities. Molecular and Cellular Probes 73, pages 101944.
Crossref
Rosa G. Rebollar-Vega, Julia M. Zuarth-Vázquez & Laura C. Hernández-Ramírez. (2023) Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease. Archives of Medical Research, pages 102899.
Crossref
Bashiru IbrahimTaiwo Hassan AkereSwaroop Chakraborty, Eugenia Valsami-Jones & Hanene Ali-Boucetta. (2023) Functionalized Gold Nanoparticles Suppress the Proliferation of Human Lung Alveolar Adenocarcinoma Cells by Deubiquitinating Enzymes Inhibition. ACS Omega 8:43, pages 40622-40638.
Crossref
Camilla Brat, Hai Phong Huynh Phuoc, Omar Awad, Bhavesh S. Parmar, Nadine Hellmuth, Ulrike Heinicke, Shady Amr, Jennifer Grimmer, Duran Sürün, Koraljka Husnjak, Max Carlsson, Jörg Fahrer, Tom Bauer, Sara-Cathrin Krieg, Georg Manolikakes, Kai Zacharowski, Dieter Steinhilber, Christian Münch, Thorsten Jürgen Maier & Jessica Roos. (2023) Endogenous anti-tumorigenic nitro-fatty acids inhibit the ubiquitin-proteasome system by directly targeting the 26S proteasome. Cell Chemical Biology 30:10, pages 1277-1294.e12.
Crossref
Alison Sparks, Christopher J. Kelly & Mark K. Saville. (2022) Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2 . FEBS Letters 596:21, pages 2746-2767.
Crossref
Manos C. Vlasiou, Kyriacos Ioannou, Constantina Eleftheriou, Kyriaki S. Pafiti, Lefteris C. Zacharia & Mohamed El-Shazly. (2022) Synthesis and biological evaluation of a new chalconate Co (II/III) complex with cytotoxic activity. Journal of Molecular Structure 1249, pages 131567.
Crossref
Hao Luo, Yanjie Ji, Xinrong Gao, Xinying Liu, Yunzhao Wu & Yingli Wu. (2022) Ubiquitin Specific Protease 2: Structure% Isoforms% Cellular Function% Related Diseases and Its Inhibitors. Oncologie 24:1, pages 85-99.
Crossref
Balsam Rizeq, Ishita Gupta, Hadeel Kheraldine, Dana Elkhalifa, Halema F. Al-Farsi, Ala-Eddin Al Moustafa & Ashraf Khalil. (2021) Novel Nitrogen-Based Chalcone Analogs Provoke Substantial Apoptosis in HER2-Positive Human Breast Cancer Cells via JNK and ERK1/ERK2 Signaling Pathways. International Journal of Molecular Sciences 22:17, pages 9621.
Crossref
Lucas Cruz, Paula Soares & Marcelo Correia. (2021) Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes. Pharmaceuticals 14:9, pages 848.
Crossref
Gen Li, Tianquan Yang, Yanling Chen, Jianping Bao, Di Wu, Xiaohan Hu, Chenxi Feng, Lixiao Xu, Mei Li, Gang Li, Meifang Jin, Yunyun Xu, Rui Zhang, Guanghui Qian & Jian Pan. (2021) USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1. Frontiers in Pharmacology 12.
Crossref
Hyeon-Ah Do & Kwang-Hyun Baek. (2021) Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases. Ageing Research Reviews 69, pages 101367.
Crossref
Joana Moreira, Joana Almeida, Lucília Saraiva, Honorina Cidade & Madalena Pinto. (2021) Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness. Molecules 26:12, pages 3737.
Crossref
Tingting Zou & Zhenghong Lin. (2021) The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression. International Journal of Molecular Sciences 22:11, pages 5754.
Crossref
Shiyao Chen, Yunqi Liu & Huchen Zhou. (2021) Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors. International Journal of Molecular Sciences 22:9, pages 4546.
Crossref
Hsin-Cheng Lin, Ying Kuan, Hsu-Feng Chu, Shu-Chun Cheng, Heng-Chih Pan, Wei-Yi Chen, Chiao-Yin Sun & Ta-Hsien Lin. (2021) Disulfiram and 6-Thioguanine synergistically inhibit the enzymatic activities of USP2 and USP21. International Journal of Biological Macromolecules 176, pages 490-497.
Crossref
Huanjie Yang, Xin Chen, Kai Li, Hassan Cheaito, Qianqian Yang, Guojun Wu, Jinbao Liu & Q. Ping Dou. (2021) Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment. Seminars in Cancer Biology 68, pages 105-122.
Crossref
Divya Nedungadi, Anupama Binoy, Nanjan Pandurangan, Bipin G. Nair & Nandita Mishra. (2020) Proteasomal dysfunction and ER stress triggers 2′‐hydroxy‐retrochalcone‐induced paraptosis in cancer cells. Cell Biology International 45:1, pages 164-176.
Crossref
Aleksandra Pawlak, Marta Henklewska, Beatriz Hernández Suárez, Mateusz Łużny, Ewa Kozłowska, Bożena Obmińska-Mrukowicz & Tomasz Janeczko. (2020) Chalcone Methoxy Derivatives Exhibit Antiproliferative and Proapoptotic Activity on Canine Lymphoma and Leukemia Cells. Molecules 25:19, pages 4362.
Crossref
Xing Huang, Xiaozhen Zhang, Jian Xu, Xun Wang, Gang Zhang, Tianyu Tang, Xiaochao Shen, Tingbo Liang & Xueli Bai. (2020) Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity. Frontiers in Oncology 10.
Crossref
Ainsley Mike Antao, Apoorvi Tyagi, Kye-Seong Kim & Suresh Ramakrishna. (2020) Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics. Cancers 12:6, pages 1579.
Crossref
Jennifer A. Ward, Adan Pinto-Fernandez, Loïc Cornelissen, Sarah BonhamLaura Díaz-SáezOlivier Riant, Kilian V. M. Huber, Benedikt M. KesslerOlivier Feron & Edward W. Tate. (2020) Re-Evaluating the Mechanism of Action of α,β-Unsaturated Carbonyl DUB Inhibitors b-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Cross-linking with Michael Acceptor Motif-Containing Drugs. Journal of Medicinal Chemistry 63:7, pages 3756-3762.
Crossref
Xiaonan Zhang, Stig Linder & Martina Bazzaro. (2020) Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers. Cancers 12:4, pages 902.
Crossref
Keng Po Lai, Jian Chen & William Ka Fai Tse. (2020) Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy. International Journal of Molecular Sciences 21:7, pages 2548.
Crossref
Diana Campos-Iglesias, Carlos López-Otín & José M.P. Freije. 2020. Cancer-Leading Proteases. Cancer-Leading Proteases 73 120 .
Ming-Jer Young, Kai-Cheng Hsu, Tony Eight Lin, Wen-Chang Chang & Jan-Jong Hung. (2019) The role of ubiquitin-specific peptidases in cancer progression. Journal of Biomedical Science 26:1.
Crossref
Ganga B. Vamisetti, Roman Meledin, Pushparathinam Gopinath & Ashraf Brik. (2018) Halogen Substituents in the Isoquinoline Scaffold Switches the Selectivity of Inhibition between USP2 and USP7. ChemBioChem.
Crossref
Nishi Kumari, Kwok Kin Lee & Sudhakar Jha. 2018. Neoplasm. Neoplasm.
Kush Patel, Zainab SO Ahmed, Xuemei Huang, Qianqian Yang, Elmira Ekinci, Christine M Neslund-Dudas, Bharati Mitra, Fawzy AEM Elnady, Young-Hoon Ahn, Huanjie Yang, Jinbao Liu & Qing Ping Dou. (2018) Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition. Future Medicinal Chemistry 10:17, pages 2087-2108.
Crossref
Cora Ballmann, Anne Thiel, Hannah E Korah, Anna-Carinna Reis, Wolfgang Saeger, Stefanie Stepanow, Karl Köhrer, Guido Reifenberger, Christiane B Knobbe-Thomsen, Ulrich J Knappe & Ute I Scholl. (2018) USP8 Mutations in Pituitary Cushing Adenomas—Targeted Analysis by Next-Generation Sequencing. Journal of the Endocrine Society 2:3, pages 266-278.
Crossref
Shang-Ju Chuang, Shu-Chun Cheng, Hui-Chi Tang, Chiao-Yin Sun & Chi-Yuan Chou. (2018) 6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2. Scientific Reports 8:1.
Crossref
Sonia Ciotti, Riccardo Sgarra, Andrea Sgorbissa, Carlotta Penzo, Andrea Tomasella, Federico Casarsa, Fabio Benedetti, Federico Berti, Guidalberto Manfioletti & Claudio Brancolini. (2018) The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffold. Cell Death & Disease 9:2.
Crossref
Nishi Kumari, Patrick William Jaynes, Azad Saei, Prasanna Vasudevan Iyengar, John Lalith Charles Richard & Pieter Johan Adam Eichhorn. (2017) The roles of ubiquitin modifying enzymes in neoplastic disease. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:2, pages 456-483.
Crossref
Xin Chen, Qianqian Yang, Lu Xiao, Daolin Tang, Q. Ping Dou & Jinbao Liu. (2017) Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents. Cancer and Metastasis Reviews 36:4, pages 655-668.
Crossref
Swee Keong Yeap, Nadiah Abu, Nadeem Akthar, Wan Yong Ho, Huynh Ky, Sheau Wei Tan, Noorjahan Banu Alitheen & Tunku Kamarul. (2016) Gene Expression Analysis Reveals the Concurrent Activation of Proapoptotic and Antioxidant-Defensive Mechanisms in Flavokawain B–Treated Cervical Cancer HeLa Cells. Integrative Cancer Therapies 16:3, pages 373-384.
Crossref
Mingjing He, Zhuan Zhou, George Wu, Qianming Chen & Yong Wan. (2017) Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication. Pharmacology & Therapeutics 177, pages 96-107.
Crossref
Yu-kai Su, Wen-Chien Huang, Wei-Hwa Lee, Oluwaseun Adebayo Bamodu, Muhammad Ary Zucha, Indwiani Astuti, Heri Suwito, Chi-Tai Yeh & Chien-Min Lin. (2017) Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication. Tumor Biology 39:5, pages 101042831769168.
Crossref
Wei-Lin Jin, Xiao-Yuan Mao & Guan-Zhong Qiu. (2017) Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges. Medicinal Research Reviews 37:3, pages 627-661.
Crossref
Katarzyna Magiera, Marcin Tomala, Katarzyna Kubica, Virginia De Cesare, Matthias Trost, Bartosz J. Zieba, Neli Kachamakova-Trojanowska, Marcin Les, Grzegorz Dubin, Tad A. Holak & Lukasz Skalniak. (2017) Lithocholic Acid Hydroxyamide Destabilizes Cyclin D1 and Induces G 0 /G 1 Arrest by Inhibiting Deubiquitinase USP2a. Cell Chemical Biology 24:4, pages 458-470.e18.
Crossref
Mingjing He, Zhuan Zhou, Anil A. Shah, Haojing Zou, Jin Tao, Qianming Chen & Yong Wan. (2016) The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics. Cell & Bioscience 6:1.
Crossref
Mindy I. Davis, Rajan Pragani, Jennifer T. Fox, Min Shen, Kalindi Parmar, Emily F. Gaudiano, Li Liu, Cordelle Tanega, Lauren McGee, Matthew D. Hall, Crystal McKnight, Paul Shinn, Henrike Nelson, Debasish Chattopadhyay, Alan D. D'Andrea, Douglas S. Auld, Larry J. DeLucas, Zhuyin Li, Matthew B. Boxer & Anton Simeonov. (2016) Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models. Journal of Biological Chemistry 291:47, pages 24628-24640.
Crossref
Ju-feng Sun, Gui-ge Hou, Feng Zhao, Wei Cong, Hong-juan Li, Wen-shuai Liu & Chunhua Wang. (2016) Synthesis, Antiproliferative, and Multidrug Resistance Reversal Activities of Heterocyclic α , β -Unsaturated Carbonyl Compounds . Chemical Biology & Drug Design 88:4, pages 534-541.
Crossref
Nishant Singh & Anuradha Bharara Singh. (2016) Deubiquitinases and cancer: A snapshot. Critical Reviews in Oncology/Hematology 103, pages 22-26.
Crossref
Lei Li, Si-Yu Zhang, Yan-Mei Li & Yong-Xiang Chen. (2016) Dual-labeling of ubiquitin proteins by chemoselective reactions for sensing UCH-L3. Molecular BioSystems 12:6, pages 1764-1767.
Crossref
Xin Wang, Pádraig D'Arcy, Thomas R. Caulfield, Aneel Paulus, Kasyapa Chitta, Chitralekha Mohanty, Joachim Gullbo, Asher Chanan-Khan & Stig Linder. (2015) Synthesis and Evaluation of Derivatives of the Proteasome Deubiquitinase Inhibitor b-AP15. Chemical Biology & Drug Design 86:5, pages 1036-1048.
Crossref
Karthik Selvaraju, Magdalena Mazurkiewicz, Xin Wang, Joachim Gullbo, Stig Linder & Pádraig D’Arcy. (2015) Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?. Drug Resistance Updates 21-22, pages 20-29.
Crossref
Debarshi Kar Mahapatra, Sanjay Kumar Bharti & Vivek Asati. (2015) Anti-cancer chalcones: Structural and molecular target perspectives. European Journal of Medicinal Chemistry 98, pages 69-114.
Crossref
Chong Shi, Guo-Bin Zhang & Shu-Wang Yin. (2015) Effect of bortezomib on migration and invasion in cervical carcinoma HeLa cell. Asian Pacific Journal of Tropical Medicine 8:6, pages 485-488.
Crossref
Padraig D'Arcy, Xin Wang & Stig Linder. (2015) Deubiquitinase inhibition as a cancer therapeutic strategy. Pharmacology & Therapeutics 147, pages 32-54.
Crossref
Pierfausto Seneci. 2015. Chemical Modulators of Protein Misfolding and Neurodegenerative Disease. Chemical Modulators of Protein Misfolding and Neurodegenerative Disease 73 94 .
Mario F. Navarro, Lisa Carmody, Octavio Romo-Fewell, Melissa E. Lokensgard & John J. Love. (2014) Characterizing Substrate Selectivity of Ubiquitin C-Terminal Hydrolase-L3 Using Engineered α-Linked Ubiquitin Substrates. Biochemistry 53:51, pages 8031-8042.
Crossref
Markus E. Diefenbacher, Nikita Popov, Sophia M. Blake, Christina Sch?lein-V?lk, Emma Nye, Bradley Spencer-Dene, Laura A. Jaenicke, Martin Eilers & Axel Behrens. (2014) The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer. Journal of Clinical Investigation 124:8, pages 3407-3418.
Crossref
Mei-Na Cao, Yu-Bo Zhou, An-Hui Gao, Jia-Yi Cao, Li-Xin Gao, Li Sheng, Lei Xu, Ming-Bo Su, Xian-Chao Cao, Meng-meng Han, Ming-Kui Wang & Jia Li. (2014) Curcusone D, a novel ubiquitin–proteasome pathway inhibitor via ROS-induced DUB inhibition, is synergistic with bortezomib against multiple myeloma cell growth. Biochimica et Biophysica Acta (BBA) - General Subjects 1840:6, pages 2004-2013.
Crossref
Kwang-Hyun Baek, Key-Hwan Lim & Jang-Joon Park. 2014. Resistance to Proteasome Inhibitors in Cancer. Resistance to Proteasome Inhibitors in Cancer 365 385 .
Xavier Jacq, Mark Kemp, Niall M. B. Martin & Stephen P. Jackson. (2013) Deubiquitylating Enzymes and DNA Damage Response Pathways. Cell Biochemistry and Biophysics 67:1, pages 25-43.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.